| Literature DB >> 25177730 |
Elvia Hernández-Hernández1, Carlos Regalado-González1, Pedro Vázquez-Landaverde2, Isabel Guerrero-Legarreta3, Blanca E García-Almendárez1.
Abstract
The effect of solvent polarity (methanol and pentane) on the chemical composition of hydrodistilled essential oils (EO's) of Lippia graveolens H.B.K. (MXO) and Origanum vulgare L. (EUO) was studied by GC-MS. Composition of modified starch microencapsulated EO's was conducted by headspace-solid-phase microextraction (HS-SPME). The antimicrobial activity of free and microencapsulated EO's was evaluated. They were tested against Salmonella sp., Brochothrix thermosphacta, Pseudomonas fragi, Lactobacillus plantarum, and Micrococcus luteus. Thymol and carvacrol were among the main components of EO's and their free and microencapsulated inhibitory activity was tested against M. luteus, showing an additive combined effect. Chemical composition of EO's varied according to the solvent used for GC analysis and to volatile fraction as evaluated by HS-SPME. Thymol (both solvents) was the main component in essential oil of MXO, while carvacrol was the main component of the volatile fraction. EUO showed α-pinene (methanol) and γ-terpinene (pentane) as major constituents, the latter being the main component of the volatile fraction. EO's showed good stability after 3 months storage at 4°C, where antimicrobial activity of microencapsulated EO's remained the same, while free EO's decreased 41% (MXO) and 67% (EUO) from initial activity. Microencapsulation retains most antimicrobial activity and improves stability of EO's from oregano.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25177730 PMCID: PMC4142163 DOI: 10.1155/2014/641814
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Composition of Origanum vulgare and Lippia graveolens essential oils diluted with methanol and pentanea.
| Number | Compound | Composition (% peak area) | KIb | KIc | Identification | Reference | |||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| 1 | Dimethyl sulfide | 0.00 | 0.01 | 515 | 505 | KI, MS | [ | ||
| 2 | 2-Methyl-propanal | 0.01 | 547 | 552 | KI, MS | [ | |||
| 3 | Cyclopentane | 0.18 | 551 | 560 | KI, MS | [ | |||
| 4 | Trichloromethane | 0.001 | 614 | 616 | KI, MS | [ | |||
| 5 | 3-Methyl-butanal | 0.01 | 0.01 | 0.01 | 644 | 649 | KI, MS | [ | |
| 6 | 2-Methyl-butanal | 0.01 | 0.01 | 654 | 658 | KI, MS | [ | ||
| 7 | 2-Ethyl-furan | 0.001 | 0.01 | 0.01 | 696 | 691 | KI, MS | [ | |
| 8 | 2-Methyl-propanoic acid ethyl ester | 0.01 | 0.01 | 757 | 755 | KI, MS | [ | ||
| 9 | Acetic acid 2-methylpropyl ester | 0.01 | 0.02 | 774 | 779 | KI, MS | [ | ||
| 10 | 2-Methyl-butanoic acid methyl ester | 0.01 | 0.01 | 777 | 780 | KI, MS | [ | ||
| 11 | 3-Methyl-2-butenal | 0.01 | 0.01 | 785 | 783.3 | KI, MS | [ | ||
| 12 | 2-Methyl-butanoic acid ethyl ester | 0.03 | 0.03 | 852 | 848 | KI, MS | [ | ||
| 13 | 2-Hexenal | 0.05 | 0.03 | 0.03 | 857 | 854 | KI, MS | [ | |
| 14 | 3-Methyl-1-butanol acetate | 0.03 | 0.03 | 878 | 876 | KI, MS | [ | ||
| 15 | 3-Methyl-3-buten-1-ol acetate | 0.02 | 885 | 878 | KI, MS | [ | |||
| 16 |
| 4.85 | 2.30 | 15.56 | 10.38 | 925 | 926 | KI, MS | [ |
| 17 | Dehydrosabinene | 0.02 | 948 | 957 | KI, MS | [ | |||
| 18 | Camphene | 0.04 | 0.04 | 0.10 | 0.08 | 955 | 954 | KI, MS | [ |
| 19 | Benzaldehyde | 0.01 | 0.01 | 968 | 970 | KI, MS | [ | ||
| 20 |
| 2.08 | 2.32 | 2.90 | 2.59 | 977 | 977 | KI, MS | [ |
| 21 |
| 0.11 | 0.26 | 0.39 | 0.33 | 982 | 981 | KI, MS | [ |
| 22 | 3-Octanone | 0.09 | 0.07 | 987 | 985 | KI, MS | [ | ||
| 23 |
| 2.32 | 991 | 991 | KI, MS | [ | |||
| 24 | 2-Methyl-butanoic acid-2-methylpropyl ester | 0.01 | 1003 | 1004 | KI, MS | [ | |||
| 25 |
| 0.25 | 0.02 | 0.39 | 0.34 | 1010 | 1007 | KI, MS | [ |
| 26 | 3-Carene | 0.23 | 0.001 | 0.29 | 0.001 | 1012 | 1011 | KI, MS | [ |
| 27 |
| 2.02 | 2.32 | 6.95 | 5.88 | 1022 | 1024 | KI, MS | [ |
| 28 |
| 5.11 | 1031 | 1027 | KI, MS | [ | |||
| 29 |
| 4.42 | 1031 | 1029 | KI, MS | [ | |||
| 30 | D-Limonene | 0.32 | 0.37 | 1.05 | 0.89 | 1035 | 1031 | KI, MS | [ |
| 31 |
| 5.10 | 3.96 | 1039 | 1041 | KI, MS | [ | ||
| 32 | Eucalyptol | 1.02 | 0.97 | 1040 | 1036 | KI, MS | [ | ||
| 33 |
| 0.13 | 0.57 | 1042 | 1040 | KI, MS | [ | ||
| 34 | Butyl 2-methylbutanoate | 0.01 | 1043 | 1043 | KI, MS | [ | |||
| 35 |
| 0.13 | 0.69 | 0.57 | 1049 | 1050 | KI, MS | [ | |
| 36 |
| 9.59 | 10.31 | 0.21 | 15.06 | 1068 | 1063 | KI, MS | [ |
| 37 | Terpinolene | 0.17 | 0.18 | 2.26 | 1.84 | 1090 | 1089 | KI, MS | [ |
| 38 |
| 0.06 | 0.05 | 0.04 | 0.03 | 1095 | 1088 | KI, MS | [ |
| 39 |
| 0.70 | 0.61 | 1.85 | 1.51 | 1102 | 1100 | KI, MS | [ |
| 40 | 1-Octen-3-yl-acetate | 0.23 | 1107 | 1110 | KI, MS | [ | |||
| 41 |
| 0.08 | 1108 | 1105 | KI, MS | [ | |||
| 42 | neo-allo-Ocimene | 0.01 | 0.01 | 0.74 | 1130 | 1129 | KI, MS | [ | |
| 43 |
| 0.14 | 1131 | 1129 | KI, MS | [ | |||
| 44 |
| 0.04 | 1.02 | 0.82 | 1133 | 1140 | KI, MS | [ | |
| 45 |
| 0.30 | 0.26 | 1156 | 1147 | KI, MS | [ | ||
| 46 |
| 0.01 | 1167 | 1168 | KI, MS | [ | |||
| 47 | Pinocarvone | 0.03 | 0.02 | 1173 | 1168 | KI, MS | [ | ||
| 48 | 3-Thujene-2-one | 0.10 | 0.42 | 1178 | 1168 | KI, MS | [ | ||
| 49 | Terpinen-4-ol | 0.59 | 0.56 | 14.77 | 12.40 | 1190 | 1187 | KI, MS | [ |
| 50 |
| 0.19 | 0.17 | 2.32 | 1.89 | 1206 | 1203 | KI, MS | [ |
| 51 |
| 0.17 | 0.30 | 1219 | 1212 | KI, MS | [ | ||
| 52 | Thymol methyl ether | 1.32 | 1.16 | 2.54 | 2.06 | 1235 | 1235 | KI, MS | [ |
| 53 | Isothymol methyl ether | 0.10 | 0.08 | 3.20 | 1245 | 1244 | KI, MS | [ | |
| 54 | Linalyl acetate | 0.80 | 0.56 | 1252 | 1251 | KI, MS | [ | ||
| 55 | Thymol | 66.30 | 49.90 | 9.30 | 11.50 | 1288 | 1290 | KI, MS | [ |
| 56 | Carvacrol | 0.10 | 0.10 | 8.40 | 8.40 | 1300 | 1299 | KI, MS | [ |
| 57 | Bornyl acetate | 0.24 | 1303 | 1297 | KI, MS | [ | |||
| 58 | Thymol acetate | 0.07 | 0.05 | 1353 | 1352 | KI, MS | [ | ||
| 59 | Eugenol | 0.07 | 0.03 | 1362 | 1362 | KI, MS | [ | ||
| 60 | Geranyl acetate | 0.13 | 0.13 | 1379 | 1383 | KI, MS | [ | ||
| 61 | Ylangene | 0.01 | 1384 | 1375 | KI, MS | [ | |||
| 62 | Copaene | 0.03 | 0.02 | 1390 | 1382 | KI, MS | [ | ||
| 63 |
| 0.06 | 1401 | 1405 | KI, MS | [ | |||
| 64 | Isocaryophyllene | 0.01 | 1422 | 1413 | KI, MS | [ | |||
| 65 |
| 0.01 | 1422 | 1428 | KI, MS | [ | |||
| 66 | Caryophyllene | 1.87 | 1.64 | 2.15 | 1.74 | 1441 | 1444 | KI, MS | [ |
| 67 |
| 0.27 | 0.23 | 1445 | 1436 | KI, MS | [ | ||
| 68 | Farnesyl acetone B | 0.04 | 0.03 | 1453 | 1453 | KI, MS | [ | ||
| 69 |
| 0.05 | 0.04 | 1457 | 1457 | KI, MS | [ | ||
| 70 |
| 0.06 | 1459 | 1460 | KI, MS | [ | |||
| 71 | Humulene | 1.22 | 1.04 | 0.30 | 0.24 | 1477 | 1477 | KI, MS | [ |
| 72 | Alloaromadendrene | 0.05 | 1482 | 1478 | KI, MS | [ | |||
| 73 |
| 0.06 | 0.12 | 0.08 | 1492 | 1493 | KI, MS | [ | |
| 74 | Germacrene D | 0.04 | 0.71 | 1502 | 1503 | KI, MS | [ | ||
| 75 |
| 0.14 | 1510 | 1506 | KI, MS | [ | |||
| 76 |
| 0.04 | 0.03 | 1511 | 1509 | KI, MS | [ | ||
| 77 | 7-epi- | 0.02 | 0.02 | 1514 | 1522 | KI, MS | [ | ||
| 78 |
| 0.76 | 0.64 | 1519 | 1509 | KI, MS | [ | ||
| 79 |
| 0.07 | 0.04 | 0.10 | 0.08 | 1533 | 1525 | KI, MS | [ |
| 80 | Calamenene | 0.03 | 0.02 | 1539 | 1531 | KI, MS | [ | ||
| 81 | Nerolidol | 0.12 | 0.10 | 1567 | 1566 | KI, MS | [ | ||
| 82 | Spathulenol | 0.35 | 0.26 | 1598 | 1596 | KI, MS | [ | ||
| 83 | Caryophyllene oxide | 0.67 | 0.41 | 0.27 | 0.20 | 1606 | 1613 | KI, MS | [ |
| 84 | Viridiflorol | 0.04 | 0.03 | 1618 | 1620 | KI, MS | [ | ||
| 85 |
| 0.01 | 0.01 | 1653 | 1646 | KI, MS | [ | ||
| 86 |
| 0.03 | 0.02 | 0.03 | 0.02 | 1676 | 1669 | KI, MS | [ |
| 87 | 6,10,14-Trimethyl-2-pentadecanone | 0.001 | 1851 | 1856 | KI, MS | [ | |||
| Grouped components (%): | |||||||||
| Monoterpene hydrocarbons | 23 | 25 | 31 | 39 | |||||
| Oxygenated monoterpenes | 25 | 26 | 29 | 27 | |||||
| Sesquiterpene hydrocarbons | 23 | 21 | 14 | 14 | |||||
| Oxygenated sesquiterpenes | 7 | 7 | 8 | 10 | |||||
| Others | 22 | 21 | 18 | 10 | |||||
aCompositions are mean of three replicates with standard error within 5% of the mean.
bCalculated Kovats retention indices.
c Kovats retention indices reported in literature.
Headspace volatile compounds identified from microcapsules of Lippia graveolens H.B.K. and Origanum vulgare L. essential oils by headspace extraction.
| Number | Compound |
Composition | KIb | KIc | Identification method | Reference | |
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| 1 | 2-Ethyl-furan | 0.70 | 1.55 | 696 | 691 | KI, MS | [ |
| 2 | 2-Methyl-butanoic acid ethyl ester | 1.12 | 852 | 848 | KI, MS | [ | |
| 3 |
| 42.64 | 552.28 | 925 | 926 | KI, MS | [ |
| 4 | Camphene | 5.83 | 17.58 | 955 | 954 | KI, MS | [ |
| 5 | Benzaldehyde | 1.79 | 968 | 970 | KI, MS | [ | |
| 6 |
| 455.61 | 982 | 981 | KI, MS | [ | |
| 7 |
| 26.34 | 254.41 | 1010 | 1007 | KI, MS | [ |
| 8 | 3-Carene | 3.21 | 620.39 | 1012 | 1011 | KI, MS | [ |
| 9 |
| 379.89 | 1022 | 1024 | KI, MS | [ | |
| 10 |
| 1297.17 | 1031 | 1029 | KI, MS | [ | |
| 11 | D-Limonene | 31.88 | 1035 | 1031 | KI, MS | [ | |
| 12 |
| 10.11 | 133.89 | 1049 | 1050 | KI, MS | [ |
| 13 |
| 1901.53 | 3937.65 | 1068 | 1063 | KI, MS | [ |
| 14 | Terpinolene | 3.40 | 2343.48 | 1090 | 1089 | KI, MS | [ |
| 15 | neo-allo-Ocimene | 9.86 | 1130 | 1129 | KI, MS | [ | |
| 16 |
| 101.54 | 1206 | 1203 | KI, MS | [ | |
| 17 | Thymol methyl ether | 163.36 | 153.34 | 1235 | 1235 | KI, MS | [ |
| 18 | Isothymol methyl ether | 1467.36 | 1245 | 1244 | KI, MS | [ | |
| 19 | Thymol | 1097.05 | 171.95 | 1288 | 1290 | KI, MS | [ |
| 20 | Carvacrol | 2297.22 | 255.86 | 1300 | 1299 | KI, MS | [ |
| 21 | Eugenol | 1.78 | 1362 | 1362 | KI, MS | [ | |
| 22 | Ylangene | 0.62 | 1384 | 1375 | KI, MS | [ | |
| 23 | Copaene | 1.76 | 1390 | 1382 | KI, MS | [ | |
| 24 | Caryophyllene | 121.66 | 301.65 | 1441 | 1444 | KI, MS | [ |
| 25 |
| 13.13 | 1445 | 1436 | KI, MS | [ | |
| 26 | Humulene | 58.29 | 31.96 | 1477 | 1477 | KI, MS | [ |
| 27 | Alloaromadendrene | 14.72 | 1482 | 1478 | KI, MS | [ | |
| 28 | Germacrene D | 76.27 | 1502 | 1503 | KI, MS | [ | |
| 29 |
| 20.98 | 1519 | 1509 | KI, MS | [ | |
| 30 |
| 1.85 | 10.04 | 1533 | 1525 | KI, MS | [ |
aArea unit is equivalent to chromatographic peak area produced for each compound.
bCalculated Kovats retention indices.
c Kovats retention indices reported in literature.
Figure 1Micrograph of microencapsulated oregano EO, by spray drying. Magnification is 2,500x.
Free and microencapsulated thymol and carvacrol antimicrobial activity against Micrococcus luteus determined by the broth dilution method. After 2 hrs incubation at 30°C.
| Antimicrobial compound |
Concentration ( | Form | |
|---|---|---|---|
| Free (log CFU/mL) | Microencapsulated (log CFU/mL) | ||
| Thymol | 0 | 5.51Aa ± 0.12 | 5.52Aa ± 0.03 |
| 50 | 4.17Bb ± 0.11 | 5.44Aa ± 0.11 | |
| 150 | 3.67Ca ± 0.18 | 1.70Bb ± 0 | |
| 250 | 3.58Ca ± 0.12 | 1.70Bb ± 0 | |
|
| |||
| Carvacrol | 0 | 5.51Aa ± 0.12 | 5.52Aa ± 0.03 |
| 80 | 5.49Aa ± 0.08 | 4.46Bb ± 0.15 | |
| 100 | 5.33Aa ± 0.30 | 1.70Cb ± 0 | |
| 300 | 5.22Aa ± 0.24 | 1.70Cb ± 0 | |
| 500 | 3.34Ba ± 0.24 | 1.70Cb ± 0 | |
Different capital superscript letters indicate significant difference (P < 0.05) within a column, whereas different lowercase superscript letters indicate significant difference (P < 0.05) within rows.
Combined effect of thymol and carvacrol to achieve inhibition of Micrococcus luteus.
| Thymol MIC | Carvacrol MIC | Combination ( |
Thymol |
Carvacrol | FICindex | |
|---|---|---|---|---|---|---|
| Thymol | Carvacrol | |||||
| 1250 | 1000 | 750 | 500 | 0.6 | 0.5 | 1.1 |
| 750 | 300 | 0.6 | 0.3 | 0.9 | ||
| 1000 | 300 | 0.8 | 0.3 | 1.1 | ||
Inhibition zone diameters obtained with Lippia graveolens H.B.K. and Origanum vulgare L. essential oils at 15% and 25% (w/v) concentration against test organisms.
| Microorganism | Concentration of essential oil (%) | MXO | Microencapsulated | EUO | Microencapsulated |
|---|---|---|---|---|---|
|
| 15 | 26.35aB ± 0.84 | 0cB | 24.96bB ± 0.06 | 0cA |
| 25 | 29.23aA ± 0.18 | 24.85cA ± 0.26 | 27.88bA ± 0.16 | 0dA | |
|
| 15 | 0bA | 24.43aA ± 0.21 | 0bB | 0bB |
| 25 | 0bA | 24.82aA ± 0.14 | 24.96aA ± 0.02 | 24.58aA ± 0.33 | |
|
| 15 | 24.95aA ± 0.01 | 24.82bA ± 0.10 | 0cB | 0cB |
| 25 | 24.92aB ± 0.01 | 24.91aA ± 0.35 | 24.93aA ± 0.03 | 24.67aA ± 0.25 | |
|
| 15 | 24.87aB ± 0.02 | 24.93aA ± 0.21 | 0bA | 0bA |
| 25 | 24.94aA ± 0.01 | 25.02aA ± 0.23 | 0bA | 0bA | |
|
| 15 | 67.69aB ± 0.19 | 32.27bB ± 0.48 | 27.12cB ± 1.28 | 24.93dB ± 0.18 |
| 25 | 83.08aA ± 0.09 | 43.58cA ± 0.08 | 75.19bA ± 0.10 | 28.33dA ± 0.81 |
a–d: for each test microorganism, means within a row not having a common superscript letter are different (P < 0.05).
A and B: for each test microorganism, means within a column (between concentrations) not having a common superscript letter are different (P < 0.05).
Stability of free and microencapsulated Lippia graveolens H.B.K. and Origanum vulgare L. essential oils at 25% at 4°C. Antimicrobial activity is shown as inhibition zone (mm) using Micrococcus luteus.
| Refrigerated storage | MXO | Microencapsulated | EUO | Microencapsulated |
|---|---|---|---|---|
| 0 | 83.08a ± 0.09 | 43.58a ± 0.08 | 75.19a ± 0.1 | 28.33a ± 0.81 |
| 3 | 49.27b ± 0.99 | 42.74a ± 1.30 | 25b ± 0.01 | 28.17a ± 1.01 |
Means within a column not showing a common superscript letter are different (P < 0.05).